-
Fogel & Potamianos LLP Welcomes Andreea Sitaru to Corporate Practice
Los Angeles, CA – April 17, 2026 – Fogel & Potamianos LLP (F&P) is proud to announce that Andreea Sitaru has joined the firm as Of Counsel, Corporate, further strengthening its corporate practice and expanding its cross-border legal capabilities.
-
How Chambers Spotlight Rankings Build Credibility and Community: Meet Fogel & Potamianos LLP
Fogel & Potamianos is a boutique law firm with offices in Los Angeles, CA, and Austin, TX. In 2025, the firm was acknowledged in the Chambers California Spotlight Guide, ranking in the Corporate/ Commercial category.
-
Honored to Help Foster UT Austin Football Player Development – Go Longhorns!
This week, Constantine Potamianos was invited by Kevin Washington, Director of Player Development, to go talk to the University of Texas at Austin football team about what it takes to get a business successfully off the ground. This was part of UT’s commitment to exposing athletes to opportunities outside of sports and giving them the…
Category: News
Archive
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- November 2025
- October 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- January 2025
- December 2024
- July 2024
- February 2024
- October 2023
- June 2023
- March 2023
- November 2022
- September 2022
- August 2022
- May 2022
- March 2022
- January 2022
- December 2021
- November 2021
- July 2021
- February 2021
- November 2020
- October 2020
- September 2020
- December 2019
- May 2019
- April 2019
- January 2019
- December 2018
Recent Posts
- Private Equity Default on Deferred Cash Payment: A Lesson in M&A Forum Selection Clauses
- Seller Remorse Over PE Rollover Equity: A Lesson in Rollover Equity Disclaimers
- LG Electronics Attempt to Wipe Out an Advertising Startup’s Liquidity and Board Rights: A Lesson for Structuring Control Sales
- TikTok Rival Triller’s Failed Merger with AGBA: A Lesson in Post-Merger Damages Calculations
- WSP USA Services Post-Closing M&A Dispute with Versar: A Lesson in Remedy Hierarchy
